EU Medicines Regulation Achievements: EMA’...

By HEOR Staff Writer

March 16, 2026

The European Medicines Agency (EMA) Management Board highlights at its March 2026 meeting a robust year, with the adoption of the 2025 annual report...
Disrupting Prescription Drug Pricing: Mark Cuban’s Cost-Plus Vision
EU Medicine Authorizations 2025: A Milestone for Innovation and Accessibility
Epidyolex Spending in Portugal Exceeds €3 Million Amid Regulatory Delays
Driving Economic Transformation through Brain Health Investment in Africa
Novartis Drug Pricing Agreement
mRNA Vaccine Advancements: Transforming Infectious Disease Prevention and Equity
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Weight Loss: Advances in Hormone-Based Obesity Treatments
Advancing Kidney Transplant Transparency Through Patient Involvement
AI in South African Healthcare: Professionals’ Confidence in Reducing A...
Health Misinformation Autism: The Dangers of Politicized Science in Vaccine a...
The Market Dynamics of Track One Patent Strategy in Pharmaceuticals